[go: up one dir, main page]

WO2002090568A3 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use - Google Patents

Therapeutic polypeptides, nucleic acids encoding same, and methods of use Download PDF

Info

Publication number
WO2002090568A3
WO2002090568A3 PCT/US2002/014341 US0214341W WO02090568A3 WO 2002090568 A3 WO2002090568 A3 WO 2002090568A3 US 0214341 W US0214341 W US 0214341W WO 02090568 A3 WO02090568 A3 WO 02090568A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
methods
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/014341
Other languages
French (fr)
Other versions
WO2002090568A2 (en
Inventor
John P Ii Alsobrook
David W Anderson
Ferenc L Boldog
Catherine E Burgess
Stacie J Casman
Schlomit R Edinger
Karen Ellerman
Esha A Gangolli
Valerie L Gerlach
Linda Gorman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to CA002446427A priority Critical patent/CA2446427A1/en
Priority to EP02741692A priority patent/EP1539806A2/en
Priority to JP2002587627A priority patent/JP2005504514A/en
Publication of WO2002090568A2 publication Critical patent/WO2002090568A2/en
Anticipated expiration legal-status Critical
Publication of WO2002090568A3 publication Critical patent/WO2002090568A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the-polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
PCT/US2002/014341 2001-05-03 2002-05-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use Ceased WO2002090568A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002446427A CA2446427A1 (en) 2001-05-03 2002-05-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP02741692A EP1539806A2 (en) 2001-05-03 2002-05-02 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
JP2002587627A JP2005504514A (en) 2001-05-03 2002-05-02 Therapeutic polypeptides, nucleic acids encoding them, and methods of use

Applications Claiming Priority (58)

Application Number Priority Date Filing Date Title
US28839501P 2001-05-03 2001-05-03
US60/288,935 2001-05-04
US28908701P 2001-05-07 2001-05-07
US60/289,087 2001-05-07
US28962101P 2001-05-08 2001-05-08
US28962001P 2001-05-08 2001-05-08
US60/289,621 2001-05-08
US60/289,620 2001-05-08
US28981801P 2001-05-09 2001-05-09
US28981701P 2001-05-09 2001-05-09
US60/289,817 2001-05-09
US60/289,818 2001-05-09
US29019401P 2001-05-11 2001-05-11
US60/290,194 2001-05-11
US29075301P 2001-05-14 2001-05-14
US60/290,753 2001-05-14
US29118901P 2001-05-15 2001-05-15
US60/291,189 2001-05-15
US29124301P 2001-05-16 2001-05-16
US60/291,243 2001-05-16
US29200101P 2001-05-18 2001-05-18
US60/292,001 2001-05-18
US29237401P 2001-05-21 2001-05-21
US60/292,374 2001-05-21
US29258701P 2001-05-22 2001-05-22
US60/292,587 2001-05-22
US29310701P 2001-05-23 2001-05-23
US60/293,107 2001-05-23
US29358901P 2001-05-24 2001-05-24
US60/293,589 2001-05-24
US29374701P 2001-05-25 2001-05-25
US60/293,747 2001-05-25
US29411001P 2001-05-29 2001-05-29
US60/294,110 2001-05-29
US29443401P 2001-05-30 2001-05-30
US60/294,434 2001-05-30
US31219201P 2001-08-14 2001-08-14
US60/312,192 2001-08-14
US31318701P 2001-08-17 2001-08-17
US31317301P 2001-08-17 2001-08-17
US60/313,187 2001-08-17
US60/313,173 2001-08-17
US31874401P 2001-09-12 2001-09-12
US31872801P 2001-09-12 2001-09-12
US60/318,744 2001-09-12
US60/318,728 2001-09-12
US33591001P 2001-11-15 2001-11-15
US60/335,910 2001-11-15
US33394201P 2001-11-28 2001-11-28
US33389101P 2001-11-28 2001-11-28
US60/333,891 2001-11-28
US60/333,942 2001-11-28
US34577602P 2002-01-03 2002-01-03
US60/345,776 2002-01-03
US34522002P 2002-01-04 2002-01-04
US60/345,220 2002-01-04
US13607102A 2002-05-01 2002-05-01
US10/136,071 2002-05-01

Publications (2)

Publication Number Publication Date
WO2002090568A2 WO2002090568A2 (en) 2002-11-14
WO2002090568A3 true WO2002090568A3 (en) 2005-04-21

Family

ID=30119585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/014341 Ceased WO2002090568A2 (en) 2001-05-03 2002-05-02 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Country Status (3)

Country Link
EP (1) EP1539806A2 (en)
CA (1) CA2446427A1 (en)
WO (1) WO2002090568A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266674A1 (en) * 2001-09-05 2004-12-30 Mills Bradley Jay Lp mammalian proteins; related reagents
AU2003251673A1 (en) * 2002-07-31 2004-02-23 Bayer Healthcare Ag Sequence of a putative humain serine protease
AU2003280642A1 (en) * 2002-11-01 2004-05-25 Takeda Pharmaceutical Company Limited Apoptosis inducer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KAWAI J. ET AL: "Functional annotation of a full-length mouse cDNA collection", NATURE, vol. 409, 8 February 2001 (2001-02-08), pages 685 - 690, XP001009930 *

Also Published As

Publication number Publication date
CA2446427A1 (en) 2002-11-14
EP1539806A2 (en) 2005-06-15
WO2002090568A2 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
WO2002014368A8 (en) Proteins and nucleic acids encoding the same
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002064791A3 (en) Proteins and nucleic acids encoding same
WO2002057453A3 (en) Polypetides and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002057450A3 (en) Proteins and nucleic acids encoding same
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2004015060A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002029058A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001081578A3 (en) Novel proteins and nucleic acids encoding same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2002046229A3 (en) Novel proteins and nucleic acids encoding same
WO2002029038A3 (en) Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002079398A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002010216A3 (en) Proteins and nucleic acids encoding same
WO2001074904A3 (en) G-protein coupled receptors and nucleic acids encoding same
WO2001066747A8 (en) Proteins named fctrx and nucleic acids encoding same
WO2002099116A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001074851A3 (en) Novel proteins and nucleic acids encoding same
WO2002083841A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002026826A3 (en) Proteins and nucleic acids encoding same
WO2002068647A3 (en) Proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2002314769

Country of ref document: AU

Ref document number: 2002587627

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2446427

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002741692

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002741692

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 2002741692

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002741692

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)